IP Forecast: Inhibrx Co-Founder Faces Biotech Secrets Trial
A Delaware federal jury next week will hear a trade secrets lawsuit that accuses a biotech executive of helping himself to confidential information about cancer treatment antibodies while being employed as an expert...To view the full article, register now.
Already a subscriber? Click here to view full article